Researchers will use a technique called single-cell RNA sequencing to identify surface markers specific to canine hemangiosarcoma cells as a first step toward the development of a more effective and precise therapy.

Researchers will identify new therapy targets for malignant mast cell tumors, acommon and aggressive cancer in dogs.

Researchers are studying if hemangiosarcoma subtypes influence how affected dogs respond to treatment – a step toward precision medicine for these patients.

SUMMARY: Researchers will study the effects of exposure to environmental pollutants on the hemangiosarcoma risk in dogs enrolled in the Golden Retriever Lifetime Study.

Researchers will investigate the effectiveness of combining radiation therapy with an immune-stimulating agent to help slow the spread of osteosarcoma, the most common bone tumor in dogs.

Researchers are investigating the effectiveness of a novel immunotherapy to help reduce metastatic disease (cancer spread) and prolong quality of life in dogs with osteosarcoma.